MedTrace Logo

Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes

NCT06922526 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-04-30

No results posted yet for this study

Summary

Tricuspid regurgitation (TR) is a common complication following cardiac implantable electronic device (CIED) implantation, with severe TR being associated with increased rates of heart failure hospitalization and all-cause mortality, significantly impairing patients' quality of life. With technological advancements, physiological pacing modalities have demonstrated superior clinical efficacy and safety profiles compared to conventional pacing methods.

This study aims to evaluate predictors of adverse outcomes and TR progression in CIED recipients under different pacing modalities, thereby providing clinical guidance for high-risk patients.

Conditions

  • Tricuspid Regurgitation
  • Pacemaker

Interventions

DEVICE

Pacemaker implantation

Pacemaker implantation methods include right ventricular pacing, biventricular pacing, conduction system pacing

Sponsors & Collaborators

  • Haiyan Wang

    lead OTHER

Principal Investigators

  • Haiyan Wang, MD · Shandong First Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2026-03-31
Completion
2026-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06922526 on ClinicalTrials.gov